Lysosomal And Rare Disorders Research And Treatment Center Inc
Fairfax, Virginia
Financial Health Score
9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.
Above Average
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Filing History
8 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $3,351,390↑11% | $3,676,714↑49% | $1,851,613↓14% | |
| 2022 | $3,020,151↑13% | $2,474,219↑18% | $2,144,032↑31% | — |
| 2021 | $2,664,551↑38% | $2,093,309↓5% | $1,635,612↑96% | — |
| 2020 | $1,934,480↓1% | $2,201,912↑15% | $834,123↑65% | — |
| 2019 | $1,956,593↑421% | $1,919,918↑447% | $504,338↑457% | — |
| 2016 | $375,235↑92% | $350,671↑61% | $90,619↓57% | — |
| 2015 | $195,193↑28% | $218,436↑39% | $208,448↑47% | — |
| 2014 | $152,334 | $157,699 | $142,188 | — |
Frequently Asked Questions
What does Lysosomal And Rare Disorders Research And Treatment Center Inc do?▼
Lysosomal And Rare Disorders Research And Treatment Center Inc is a medical research nonprofit organization based in Virginia. It is classified under NTEE code H80 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Lysosomal And Rare Disorders Research And Treatment Center Inc financially healthy?▼
Based on our 9-metric Financial Health Score model, Lysosomal And Rare Disorders Research And Treatment Center Inc has a score of 58/100 (Grade: B). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.
How much revenue does Lysosomal And Rare Disorders Research And Treatment Center Inc generate?▼
Lysosomal And Rare Disorders Research And Treatment Center Inc reports $4.4M in annual revenue and holds $2.4M in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in Virginia.